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The genetic basis of congenital glaucoma with systemic anomalies is largely
unknown. Whole exome sequencing (WES) in 10 probands with congenital
glaucoma and variable systemic anomalies identified pathogenic or likely
pathogenic variants in three probands; in two of these, a combination of two
Mendelian disorders was found to completely explain the patients’ features
whereas in the third case only the ocular findings could be explained by the
genetic diagnosis. The molecular diagnosis for glaucoma included two cases
with compound heterozygous or homozygous pathogenic alleles in CYP1B1
and one family with a dominant pathogenic variant in FOXC1; the second
genetic diagnosis for the additional systemic features included compound
heterozygous mutations in NPHS1 in one family and a heterozygous 18q23
deletion in another pedigree. These findings show the power of WES in the
analysis of complex conditions and emphasize the importance of CYP1B1
screening in patients with congenital glaucoma regardless of the
presence/absence of other systemic anomalies.
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Congenital glaucoma, also referred to as infantile,
is characterized by onset in newborns or diagnosed
in the first 2 years of life and may be classified as
primary (PCG) in the absence of visible structural
ocular anomalies or developmental when associated
with anterior segment dysgenesis (1). CYP1B1 is the
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most common genetic cause of isolated congenital
glaucoma, typically PCG, with mutations in LTBP2
occasionally reported as well (1, 2). Numerous genes
have been identified in specific ocular syndromes
involving congenital/infantile glaucoma in some cases
including FOXC1 and PITX2 (Axenfeld–Rieger syn-
drome), OCRL1 (Lowe syndrome), B3GLCT (Peters
Plus syndrome), BMP4 (SHORT syndrome-like), TKS4
(Frank-ter Haar syndrome), CREBBP (Rubinstein-Taybi
syndrome), POMT1, POMT2, and POMGNT1 [Walker
Warburg and muscle-eye-brain (MEB) disease], SBF2
(Charcot-Marie-Tooth Disease type 4B2), GNAQ
(Sturge–Weber syndrome), RPS19 (Diamond Black-
fan anemia), CANT1 (Desbuquois Dysplasia), BCOR
(Oculofaciocardiodental syndrome), and GJA1 (Oculo-
dentodigital dysplasia) (www.omim.org).
To evaluate the genetic causes of congenital glaucoma
with systemic anomalies, we performed whole exome
sequencing (WES) in 10 probands. This human study
was approved by the Institutional Review Board of the
Children’s Hospital of Wisconsin with written informed
consent obtained from every subject and/or their legal
representative including consent for publication of pho-
tographs when applicable. The affected phenotypes
involved congenital glaucoma with other eye anomalies,
dysmorphic facial features, and developmental delay or
cognitive impairment in the majority of patients (8/10);
additionally, short stature and/or structural birth defects
affecting the heart, kidney, brain, or genitals were each
present in about half of probands (Table S1, Support-
ing Information). WES was performed and analyzed as
described previously (3) for variants in genes associ-
ated with congenital glaucoma (Table S2); other analyses
included evaluation of variants in OMIM genes associ-
ated with pediatric conditions and/or present in ClinVar
using the lists of genes/variants as developed by Golden
Helix (Bozeman, MT, USA) and provided in their SNP
and Variation Suite (SVS) software package. Allele fre-
quency and reported pathogenicity were assessed using
the ExAC browser (http://exac.broadinstitute.org/) and
Human Gene Mutation Database (HGMD) (4). Vari-
ant pathogenicity was assessed using ACMG guide-
lines (5). Pathogenic variants were verified by Sanger
sequencing in the probands and available family mem-
bers. Exome sequencing data was also screened for
copy number variation (CNV) using Copy Number
Inference From Exome Reads (CoNIFER) v0.2.2
software (http://conifer.sourceforge.net/); CNV analysis
via Affymetrix Genome-Wide Human SNP Array 6.0
(Santa Clara, CA, USA) and TaqMan assays were also
performed as previously described in one family (6).
Pathogenic variants were submitted to the relevant lovd
3.0 shared installation databases (patient IDs 00054892,
00054893, and 00059222).
Pathogenic/likely pathogenic variants were identified
in three probands (Table 1); in two of these, a combi-
nation of two Mendelian disorders was found to fully
explain the patients’ features while in the third only
the ocular findings could be explained by the genetic
diagnosis. Review of the exome data on the remaining
seven patients for sequence and copy number variants did
not identify any pathogenic/likely pathogenic variants to
explain the congenital glaucoma or syndromic anoma-
lies.
Patient 1 (Fig. 1a,b), with bilateral congenital glau-
coma with anterior segment dysgenesis, dysmorphic
facial features, nephrotic syndrome, mild-moderate
developmental delay, short stature, and feeding difficul-
ties requiring placement of a gastric tube, was found
to have compound heterozygous pathogenic/likely
pathogenic variants in two genes: CYP1B1 and NPHS1
(Table 1); both unaffected parents were heterozygous
carriers for these variants. The CYP1B1 variants have
both been reported previously in patients with PCG (2).
Congenital nephrotic syndrome of the Finnish type is
a recessive condition caused by disruption of NPHS1
typically associated with onset in the first 3 months
of life with end-stage renal disease occurring by 2–3
years of age (7). The NPHS1 nonsense variant seen
in Patient 1 was previously reported as pathogenic
(7). The missense change is a novel variant within
the extracellular topological domain that is predicted
to be damaging and is not present in ExAC; of note
several similar missense variants affecting codons
of neighboring amino acids have been reported as
pathogenic (4).
Patient 2 (Fig. 1c,d), with congenital glaucoma and
bilateral Peters anomaly, dysmorphic facial features,
short stature, feeding issues requiring a nasogastric
tube, intracranial calcifications, nephrocalcinosis and
nephrolithiasis, and mild developmental delay, was
found to have a homozygous previously reported
pathogenic variant in CYP1B1; both unaffected par-
ents were heterozygotes. No other pathogenic/likely
pathogenic variants were identified in the whole exome
data to explain the systemic features noted in this patient.
Patient 3, with congenital glaucoma, bilateral microph-
thalmia, iris anomalies, dysmorphic facial features,
bilateral club foot (pes equinovarus), mild cognitive
impairment (IQ about 60), congenital deafness, and a
family history of variable non-congenital glaucoma,
pupil anomalies, hearing loss and club foot in the father
and paternal relatives (Fig. 1e), was found to have a
pathogenic frameshift variant in FOXC1 inherited from
the father along with a de novo 4.8Mb terminal deletion
of chromosome 18q23; Affymetrix microarray and
TaqMan analysis confirmed the deletion on chromo-
some 18 from 73226420 to 78015057 in the proband
and normal copy number in the parents and siblings
(Fig. S1). While the FOXC1 variant is novel, loss of
function variants in FOXC1 are a well-established cause
of Axenfeld–Rieger syndrome type 3, associated with
developmental glaucoma (sometimes congenital), iris
anomalies, and dysmorphic facial features, with hearing
impairment or heart defects in some cases (8). Distal 18q
deletions are typically associated with cognitive impair-
ment, craniofacial anomalies, hearing impairment, foot
deformities including club foot, and short stature (9);
microcornea has been reported in several patients (10).
Thus, the congenital glaucoma and iris anomalies seen
in the proband are likely due to the FOXC1 mutation
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Fig. 1. (a) Photograph of Patient 1 at 23 months of age with scaphocephaly, thin upper lip, mild mid-face hypoplasia, and a low-set ear on one side. (b)
Pedigree of Patient 1 (marked with black arrow) with genotype information. (c) Photograph of Patient 2 at ∼20months of age. The patient demonstrated
low-set posteriorly rotated ears, thin upper lip, maxillary hypoplasia, and deep set eyes. (d) Pedigree of Patient 2 (marked with black arrow) with
genotype information. (e) Pedigree of Patient 3 (marked with black arrow) with genotype information.
fit better with the 18q23 deletion, although in this case
club foot is also observed in the father and other paternal
relatives. Because FOXC1 deficiency and 18q dele-
tions are both linked with dysmorphic facial features
(midface hypoplasia, hypertelorism), hearing impair-
ment, and ocular defects, the severe ocular and hearing
features seen in Patient 3, congenital deafness and
microphthalmia, are probably a result of the combined
effect of the two genetic conditions.
WES was able to establish a genetic diagnosis in 30%
(3/10) of probands affected with congenital glaucoma
with systemic anomalies. Because these patients did not
have features which fit with known glaucoma syndromes,
it is not surprising that few of them had mutations
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in the known genes. Our rate of diagnosis (30%) is
similar to the 25% success rate in other published exome
analysis studies in cohorts of pediatric patients with an
‘undiagnosed disease’ (11). While blended phenotypes
resulting from two single gene disorders were reported
in the previous exome study [23/504 (4.6%) of explained
cases] (11), multiple diagnoses were identified in 67% of
explained cases in our cohort, suggesting that congenital
glaucoma with systemic anomalies that does not fit any
specific syndrome may be more likely to be explained
by two molecular diagnoses; further analysis is needed
because it is possible that this increased rate is the result
of the small sample size. The co-occurrence of two
genetic conditions resulting from disruption of genes
on different chromosomes would be expected to be
a rare event. It is interesting to note that while the
first patient’s phenotype resulted from a combination
of two distinct genetic conditions (congenital glaucoma
and nephrotic syndrome), the third patient exhibited
two genetic conditions with overlapping features and
possible genetic interaction between the involved genes.
The identification ofCYP1B1mutations in two patients
with congenital glaucoma with systemic anomalies high-
lights the importance ofCYP1B1 screening in these cases
despite its strong association with isolated PCG. Overall,
these data suggest that WES is a useful tool for the diag-
nosis of congenital glaucoma with systemic anomalies.
Supporting Information
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